The Centers for Disease Control and Prevention (CDC) recently published their updated vaccine recommendations for the 2016-2017 influenza season.
Major changes and updates include:
- Antigenic composition and influenza vaccine products information for the 2016-17 season
- Interim recommendation that live attenuated influenza vaccine (LAIV4) should not be used for the 2016-17 season
- Providers should consider observing ALL patients for 15 minutes after vaccination instead of 30 minutes post vaccination for egg-allergic recipients only
- Persons with a history of egg allergy who have experienced only hives after exposure to egg should receive influenza vaccine
- Persons with a history of severe allergic reaction to egg (i.e., any symptom other than hives) should be vaccinated in an inpatient or outpatient medical setting, under the supervision of a health care provider who is able to recognize and manage severe allergic conditions